NMRA Investors are Suing Neumora Therapeutics, Inc.; Contact Robbins LLP for More Information
SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant to the …